Shenyi Jiang

491 total citations
22 papers, 371 citations indexed

About

Shenyi Jiang is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Shenyi Jiang has authored 22 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Molecular Biology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Shenyi Jiang's work include Cytokine Signaling Pathways and Interactions (5 papers), Cancer-related Molecular Pathways (4 papers) and Medicinal Plant Pharmacodynamics Research (3 papers). Shenyi Jiang is often cited by papers focused on Cytokine Signaling Pathways and Interactions (5 papers), Cancer-related Molecular Pathways (4 papers) and Medicinal Plant Pharmacodynamics Research (3 papers). Shenyi Jiang collaborates with scholars based in China, Germany and Belgium. Shenyi Jiang's co-authors include Youhong Jiang, Jing Sun, Liping Xia, Shun‐Dong Dai, Xin Tian, Suqin Wu, Jing Lu, Lin Yuan, Hui Shen and Yunxia Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Ethnopharmacology.

In The Last Decade

Shenyi Jiang

20 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shenyi Jiang China 12 149 101 89 54 44 22 371
Esther López-Rivera United States 7 211 1.4× 96 1.0× 135 1.5× 85 1.6× 64 1.5× 8 461
Chenchen Han China 12 237 1.6× 82 0.8× 98 1.1× 77 1.4× 22 0.5× 25 439
Gergely Groma Hungary 12 106 0.7× 143 1.4× 109 1.2× 40 0.7× 66 1.5× 21 383
Sven Radetzky Germany 8 177 1.2× 100 1.0× 97 1.1× 32 0.6× 27 0.6× 10 651
Wangmi Liu China 11 106 0.7× 100 1.0× 84 0.9× 51 0.9× 20 0.5× 23 354
Xuedong Chi United States 7 84 0.6× 203 2.0× 47 0.5× 28 0.5× 86 2.0× 8 406
Sribalaji Lakshmikanthan United States 9 230 1.5× 46 0.5× 84 0.9× 58 1.1× 59 1.3× 19 410
Phyllus Y. Mong United States 7 465 3.1× 79 0.8× 94 1.1× 46 0.9× 46 1.0× 8 652
Tiffany Tseng United States 6 319 2.1× 132 1.3× 99 1.1× 85 1.6× 43 1.0× 8 659
Baoen Jiang China 8 196 1.3× 44 0.4× 25 0.3× 81 1.5× 33 0.8× 10 384

Countries citing papers authored by Shenyi Jiang

Since Specialization
Citations

This map shows the geographic impact of Shenyi Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenyi Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenyi Jiang more than expected).

Fields of papers citing papers by Shenyi Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shenyi Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenyi Jiang. The network helps show where Shenyi Jiang may publish in the future.

Co-authorship network of co-authors of Shenyi Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Shenyi Jiang. A scholar is included among the top collaborators of Shenyi Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenyi Jiang. Shenyi Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Chengliang, Shuliang Dong, Shenyi Jiang, et al.. (2025). Network pharmacology and experimental validation uncover how Shoutai pills improve ovarian function in postpartum depression following a secondary birth. Journal of Ethnopharmacology. 355(Pt B). 120668–120668.
2.
Meng, Jia, Lingxi Zhou, Shenyi Jiang, et al.. (2022). Mapping Organizational Changes of Fiber‐Like Structures in Disease Progression by Multiparametric, Quantitative Imaging (Laser Photonics Rev. 16(6)/2022). Laser & Photonics Review. 16(6). 1 indexed citations
3.
Ning, Jing, Shenyi Jiang, Xiaoxi Li, et al.. (2021). GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma. BMC Pulmonary Medicine. 21(1). 199–199. 13 indexed citations
4.
Jiang, Shenyi, Rui Wang, Chloe M. Hall, et al.. (2021). Knock-in models related to Alzheimer’s disease: synaptic transmission, plaques and the role of microglia. Molecular Neurodegeneration. 16(1). 47–47. 43 indexed citations
5.
Li, Yuxuan, Lin Yuan, Shenyi Jiang, et al.. (2019). Interleukin-35 stimulates tumor necrosis factor-α activated osteoblasts differentiation through Wnt/β-catenin signaling pathway in rheumatoid arthritis. International Immunopharmacology. 75. 105810–105810. 24 indexed citations
6.
Han, Mei‐Ling, Shenyi Jiang, Lin Yuan, et al.. (2018). Elevation of Serum IL-35 in Patients with Primary Sjögren's Syndrome. Journal of Interferon & Cytokine Research. 38(10). 452–456. 10 indexed citations
7.
Liu, Xiaodan, Shenyi Jiang, Xin Tian, & Youhong Jiang. (2018). Expression of cleaved caspase-3 predicts good chemotherapy response but poor survival for patients with advanced primary triple-negative breast cancer.. PubMed. 11(9). 4363–4373. 11 indexed citations
8.
Wu, Suqin, Yuxuan Li, Lutian Yao, et al.. (2018). Interleukin-35 inhibits angiogenesis through STAT1 signalling in rheumatoid synoviocytes.. PubMed. 36(2). 223–227. 18 indexed citations
9.
10.
Jiang, Shenyi, Yuxuan Li, Lin Yuan, et al.. (2016). IL-35 Inhibits Angiogenesis through VEGF/Ang2/Tie2 Pathway in Rheumatoid Arthritis. Cellular Physiology and Biochemistry. 40(5). 1105–1116. 49 indexed citations
11.
Tian, Xin, Shun‐Dong Dai, Jing Sun, Shenyi Jiang, & Youhong Jiang. (2016). Association between TP53 Arg72Pro polymorphism and leukemia risk: a meta-analysis of 14 case-control studies. Scientific Reports. 6(1). 24097–24097. 22 indexed citations
12.
Tian, Xin, Shun‐Dong Dai, Jing Sun, et al.. (2016). Inhibition of MDM2 Re-Sensitizes Rapamycin Resistant Renal Cancer Cells via the Activation of p53. Cellular Physiology and Biochemistry. 39(5). 2088–2098. 13 indexed citations
13.
Li, Yaming, et al.. (2016). Lentivirus-mediated knockdown of NLK inhibits small-cell lung cancer growth and metastasis. Drug Design Development and Therapy. Volume 10. 3737–3746. 8 indexed citations
14.
Wu, Suqin, Yunxia Li, Yuxuan Li, et al.. (2016). Interleukin-35 attenuates collagen-induced arthritis through suppression of vascular endothelial growth factor and its receptors. International Immunopharmacology. 34. 71–77. 20 indexed citations
15.
Liu, Yang, Xin Tian, Shenyi Jiang, et al.. (2015). Umbilical cord blood-derived dendritic cells infected by adenovirus for SP17 expression induce antigen-specific cytotoxic T cells against NSCLC cells. Cellular Immunology. 298(1-2). 18–24. 7 indexed citations
16.
Jiang, Youhong, Ying Dai, Xin Tian, et al.. (2015). Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis. Drug Design Development and Therapy. 9. 4431–4431. 7 indexed citations
17.
Tian, Xin, Shun‐Dong Dai, Jing Sun, et al.. (2015). F-box protein FBXO22 mediates polyubiquitination and degradation of KLF4 to promote hepatocellular carcinoma progression. Oncotarget. 6(26). 22767–22775. 43 indexed citations
18.
Tian, Xin, Shun‐Dong Dai, Jing Sun, et al.. (2015). Bufalin Induces Mitochondria-Dependent Apoptosis in Pancreatic and Oral Cancer Cells by Downregulating hTERT Expression via Activation of the JNK/p38 Pathway. Evidence-based Complementary and Alternative Medicine. 2015. 1–12. 26 indexed citations
19.
Jiang, Shenyi & Xia Li. (2009). Improved BIRCH clustering algorithm. Journal of Computer Applications. 29(1). 293–296. 5 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Esther López-Rivera Breakdown of academic impact, for papers by Chenchen Han Breakdown of academic impact, for papers by Gergely Groma Breakdown of academic impact, for papers by Sven Radetzky Breakdown of academic impact, for papers by Wangmi Liu Breakdown of academic impact, for papers by Xuedong Chi Breakdown of academic impact, for papers by Sribalaji Lakshmikanthan Breakdown of academic impact, for papers by Phyllus Y. Mong Breakdown of academic impact, for papers by Tiffany Tseng Breakdown of academic impact, for papers by Baoen Jiang
Rankless by CCL
2026